NEW MJ NEWS

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-2022-earnings-conference-call-301711231.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

subsidiary of International Consolidated Companies, Inc. (INCC) books 1.5MM Revenue

BluDog books 1.5MM Revenue and Reduces Debt by $188k BluDog Products LLC,…

$ERBB Expands its Company CBD Store

American Green Expands its Company CBD Store American Green, Inc. ( OTC…

Verano Holdings Corp. (VRNOF) Strengthens Connecticut Retail Footprint with the Opening of Zen Leaf Naugatuck

Verano Strengthens Connecticut Retail Footprint with the Opening of Zen Leaf Naugatuck,…

$GBLX Secures Four New Nevada State Medical Cannabis Licenses

GrowBLOX Sciences Secures Four New Nevada State Medical Cannabis Licenses   Continues…